Attila Kollár

2.1k total citations
59 papers, 863 citations indexed

About

Attila Kollár is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Attila Kollár has authored 59 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 16 papers in Epidemiology. Recurrent topics in Attila Kollár's work include Sarcoma Diagnosis and Treatment (17 papers), Neuroendocrine Tumor Research Advances (12 papers) and Lung Cancer Research Studies (11 papers). Attila Kollár is often cited by papers focused on Sarcoma Diagnosis and Treatment (17 papers), Neuroendocrine Tumor Research Advances (12 papers) and Lung Cancer Research Studies (11 papers). Attila Kollár collaborates with scholars based in Switzerland, Germany and Netherlands. Attila Kollár's co-authors include Karl T. Beer, Richard Greiner, Daniel M. Aebersold, Valentin Djonov, Jean A. Laissue, Charlotte Benson, Bernd Kasper, Emanuel Christ, Robin L. Jones and Stefan Sleijfer and has published in prestigious journals such as Journal of Clinical Oncology, Cochrane Database of Systematic Reviews and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Attila Kollár

51 papers receiving 849 citations

Peers

Countries citing papers authored by Attila Kollár

Since Specialization

Citations

This map shows the geographic impact of Attila Kollár's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Attila Kollár with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Attila Kollár more than expected).

Fields of papers citing papers by Attila Kollár

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Attila Kollár. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Attila Kollár. The network helps show where Attila Kollár may publish in the future.

Co-authorship network of co-authors of Attila Kollár

This figure shows the co-authorship network connecting the top 25 collaborators of Attila Kollár. A scholar is included among the top collaborators of Attila Kollár based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Attila Kollár. Attila Kollár is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rapidly progressive glomerulonephritis as an unusual type of renal involvement in sarcoidosis: a case report 2025 ·Journal of Medical Case Reports ·(unknown), (unknown), (unknown), (unknown), Attila Kollár, Ivana Dedinská	0
2	Potential Effect of Silymarin Supplementation on Metabolic Complications and Graft Function in Kidney Transplant Recipients—A Pilot, Monocentric Study 2025 ·Bratislavské lekárske listy/Bratislava medical journal ·(unknown), (unknown), (unknown), (unknown), Attila Kollár, Ivana Dedinská	0
3	Systematic Review of the Gonadotoxicity and Risk of Infertility of Soft Tissue Sarcoma Chemotherapies in Pre- and Postpubertal Females and Males 2024 ·Journal of Adolescent and Young Adult Oncology ·(unknown), (unknown), (unknown), (unknown), Attila Kollár, (unknown), Michael von Wolff	5
4	Keto Analogues in Patients with Chronic Kidney Disease with or Without Kidney Transplantation 2024 ·Nutrients ·(unknown), (unknown), (unknown), Attila Kollár, (unknown), Ivana Dedinská	2
5	Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies 2024 ·npj Precision Oncology ·Simon April-Monn, Philipp Kirchner, Katharina Detjen, Konstantin Bräutigam, Mafalda Trippel, Tobias Grob, Cyril Statzer, Renaud Maire, Attila Kollár, (unknown), Catarina Alisa Kunze, David Horst, Martin C. Sadowski, Jörg Schrader, Ilaria Marinoni, Bertram Wiedenmann, Aurel Perren	4
6	A Systematic Review of the Gonadotoxicity of Osteosarcoma and Ewing’s Sarcoma Chemotherapies in Postpubertal Females and Males 2024 ·Journal of Adolescent and Young Adult Oncology ·(unknown), (unknown), (unknown), (unknown), Attila Kollár, (unknown), Michael von Wolff	8
7	Flap Reconstruction Outcome Following Surgical Resection of Soft Tissue and Bone Sarcoma in the Setting of (Neo)adjuvant Therapy: A Sarcoma Center Experience 2023 ·Cancers ·(unknown), (unknown), (unknown), (unknown), Frank M. Klenke, Attila Kollár, (unknown), (unknown), Radu Olariu	3
8	The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms 2022 ·European Journal of Cancer ·Ivan Borbath, Rocio García‐Carbonero, (unknown), Paula Jiménez‐Fonseca, Ángel Castaño, (unknown), Eva Sedláčková, Attila Kollár, Emanuel Christ, Gregory Kaltsas, Beata Kos‐Kudła, Sebastian Maasberg, Chris Verslype, Ulrich‐Frank Pape	18
9	The Role of Surgical Expertise and Surgical Access in Retroperitoneal Sarcoma Resection – A Retrospective Study 2022 ·Frontiers in Surgery ·(unknown), Attila Kollár, Daniel Candinas, Guido Beldi, Anja Lachenmayer	2
10	Update on Histological Reporting Changes in Neuroendocrine Neoplasms 2021 ·Current Oncology Reports ·Konstantin Bräutigam, (unknown), Corina Kim‐Fuchs, Attila Kollár, Roman Trepp, Ilaria Marinoni, Aurel Perren	3
11	Treatment sequence in patients with neuroendocrine tumours: a nationwide multicentre, observational analysis of the Swiss neuroendocrine tumour registry 2020 ·Swiss Medical Weekly ·Attila Kollár, (unknown), Adrian F. Ochsenbein, Christoph Stettler, Roman Trepp	11
12	Early and delayed neurological manifestations of cardiac myxomas 2020 ·Clinical Neurology and Neurosurgery ·Leonidas D Panos, (unknown), Sabina Berezowska, (unknown), Attila Kollár, Claudio L. Bassetti, Mathias Sturzenegger, Heinz Krestel	8
13	Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? 2019 ·Annals of Surgical Oncology ·Elettra Merola, Anja Rinke, Stefano Partelli, Thomas M. Gress, Valentina Andreasi, Attila Kollár, Aurel Perren, Emanuel Christ, Francesco Panzuto, Andreas Pascher, Henning Jann, Ruža Arsenić, Birgit Cremer, Daniel Kaemmerer, Patrizia Kump, Rainer W. Lipp, Abbas Agaimy, Bertram Wiedenmann, Massimo Falconi, Marianne E. Pavel	42
14	Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer 2019 ·Urologic Oncology Seminars and Original Investigations ·Vera Genitsch, Attila Kollár, Gillian Vandekerkhove, (unknown), Marc A. Furrer, Matti Annala, Cameron Herberts, Armin Pycha, Joep J. de Jong, Yang Liu, (unknown), Elai Davicioni, Ewan A. Gibb, (unknown), Alexander W. Wyatt, Roland Seiler	33
15	The pararectus approach—a versatile option in pelvic musculoskeletal tumor surgery 2019 ·Journal of Orthopaedic Surgery and Research ·(unknown), Marius Keel, Attila Kollár, Klaus A. Siebenrock, Frank M. Klenke	7
16	Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors 2016 ·Journal of Nuclear Medicine ·(unknown), Piotr Radojewski, (unknown), Rebecca A. Dumont, Nicolas Marincek, Attila Kollár, Philippe Brunner, Jan Beyersmann, Jan Müller‐Brand, Helmut R. Maëcke, Markus Laimer, Martin A. Walter	7
17	Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06) 2015 ·Annals of Oncology ·Dieter Koeberle, Daniel Betticher, Roger von Moos, D. Dietrich, Peter Brauchli, (unknown), (unknown), Sun Young Rha, Markus Borner, Sandro Anchisi, Peter Moosmann, Attila Kollár, Piercarlo Saletti, A. Roth, M. Frueh, (unknown), Răzvan Popescu, (unknown), Viviane Hess, Richard Herrmann	92
18	Current management options for liposarcoma and challenges for the future 2014 ·Expert Review of Anticancer Therapy ·Attila Kollár, Charlotte Benson	22
19	Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access program 2014 ·PubMed ·Attila Kollár, Marco Maruzzo, Christina Messiou, (unknown), Aisha Miah, Juan Martín-Liberal, Khin Thway, Ellen McGrath, (unknown), Komel Khabra, Beatrice Seddon, Palma Dileo, Mark Linch, Ian Judson, Charlotte Benson	16
20	Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma 2011 ·International Journal of Hematology ·(unknown), Attila Kollár, (unknown), Ágota Szepesi, Imre Bodó, Tamás Masszi, Viktor Bérczi, Ildikó Garai	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact